Results 221 to 230 of about 457,033 (338)
Abstract Objective Antiphospholipid antibodies (aPL) are recognized to have a pivotal role in recurrent pregnancy loss (RPL) and cardiovascular disease. Therefore, we assessed the vascular function of women with RPL and examined the association with each type of aPL.
Titi Yang +11 more
wiley +1 more source
Antenatal <i>Toxoplasma gondii</i> IgG/IgM seroprevalence at the University Hospital of Cocody. [PDF]
Goran-Kouacou APV +4 more
europepmc +1 more source
The importance of methodological context in pediatric vagus nerve stimulation outcome reporting
Epilepsia, EarlyView.
Thiemo F. Dinger +2 more
wiley +1 more source
Antiphospholipid Antibodies in Severe COVID-19: Frequency, Clinical Features, and 12-Week Follow-Up. [PDF]
Hasan MN +4 more
europepmc +1 more source
The clinical features of hyper-IgM syndrome. A 4 cases report
Anna Pituch‐Noworolska +3 more
openalex +1 more source
Clinical progress note: Rubella
Abstract Rates of rubella infection and congenital rubella syndrome decreased significantly since the introduction of the rubella vaccine in 1969. Endemic rubella was declared eliminated in the United States in 2004, and since 2012, all rubella cases in the United States have been associated with infections acquired abroad.
Adam E. Gailani +2 more
wiley +1 more source
A case of transformation of Waldenström's Macroglobulinemia to diffuse large B cell lymphoma. [PDF]
Ali MB, Kline K.
europepmc +1 more source
Anti-IgM antibody-induced cell death in a human B lymphoma cell line, B104, represents a novel programmed cell death. [PDF]
Tsuyoshi Ishigami +8 more
openalex +1 more source
Clinical progress note: Hepatitis A virus
Abstract Despite a decline in hepatitis A virus (HAV) incidence following vaccine introduction, HAV remains a public health concern in the United States. Recent multi‐state outbreaks have demonstrated that HAV can re‐emerge and highlight inequities in vaccine coverage or access, outbreak response, and in those with social or health risk factors ...
James M. McCluskey III +2 more
wiley +1 more source

